Rough Rice (ZR July 2025)/ ECBOT
ZR11/8/2024 12:00:00 AM | Chg. -0.075 | Open | High | Low | Previous Close |
---|---|---|---|---|---|
15.065USD | -0.50% | 15.065 | 15.065 | 15.065 | 15.140 |
GlobeNewswire
8/22
Telix 2024 Half-Year Results: Strong Commercial Revenue and Profit Growth to Support Strategic Prior...
GlobeNewswire
8/21
Monopar Receives Clearance to Proceed with Phase 1 Therapeutic Trial of Novel Radiopharmaceutical in...
GlobeNewswire
8/14
Monopar Announces Initial Data for First Patient Dosed in Radiopharma Phase 1 Clinical Trial of MNPR...
GlobeNewswire
8/9
Monopar Therapeutics Reports Second Quarter 2024 Financial Results and Recent Developments
Newsfile Corp
7/9
Teako Mobilizes Field Crew to Copper-Cobalt-Zinc Projects Lomunda-Venna and Tydalen Utilizing Recent...
GlobeNewswire
7/9
Monopar Announces First Patient Enrolled in First-in-Human Phase 1 Trial for Its Novel Radiopharmace...
GlobeNewswire
6/25
Monopar Announces MNPR-101-RIT Abstract Accepted as a Top-Rated Oral Presentation at EANM’24
GlobeNewswire
6/20
Nusano to Host Virtual Event “Office Hours: Radiopharmaceuticals” on June 28, 2024
GlobeNewswire
6/10
Monopar Presents Data Showcasing the Appeal of uPAR as a Radiopharma Cancer Target and of its lead C...
GlobeNewswire
6/5
TRIUMPH UNVEILS LIMITED EDITION MY25 SPEED TRIPLE 1200 RR IN COLLABORATION WITH BREITLING
GlobeNewswire
5/23
FibroGen Announces Presentation of Positive Interim Data from the Phase 1b Study of FG-3246 (FOR46) ...
GlobeNewswire
5/9
Monopar Therapeutics Reports First Quarter 2024 Financial Results and Strategic Focus on its Radioph...
GlobeNewswire
5/2
Akoya Biosciences and Shanghai KR Pharmtech Announce Chinese Regulatory Agency Premarket Approval fo...
GlobeNewswire
4/18
Monopar Announces Radiopharma Presentation Selected for Society of Nuclear Medicine and Molecular Im...